Literature DB >> 17217424

Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease.

Tara L Spires1, Anthony J Hannan.   

Abstract

Neurodegenerative diseases such as Huntington's disease and Alzheimer's disease, although very different in etiology, share common degenerative processes. These include neuronal dysfunction, decreased neural connectivity, and disruption of cellular plasticity. Understanding the molecular mechanisms underlying the neural plasticity deficits in these devastating conditions may lead the way toward new therapeutic targets, both disease-specific and more generalized, which can ameliorate degenerative cognitive deficits. Furthermore, investigations of 'pathological plasticity' in these diseases lend insight into normal brain function. This review will present evidence for altered plasticity in Huntington's and Alzheimer's diseases, relate these findings to symptomatology, and review possible causes and commonalities.

Entities:  

Mesh:

Year:  2007        PMID: 17217424     DOI: 10.1111/j.1471-4159.2006.04275.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

2.  ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease.

Authors:  Pamela Maher; Richard Dargusch; Laszlo Bodai; Paul E Gerard; Judith M Purcell; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2010-10-15       Impact factor: 6.150

3.  Oxidative stress and plasma aminopeptidase activity in Huntington's disease.

Authors:  Raquel Duran; Francisco J Barrero; Blas Morales; Juan D Luna; Manuel Ramirez; Francisco Vives
Journal:  J Neural Transm (Vienna)       Date:  2010-01-22       Impact factor: 3.575

4.  Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia.

Authors:  Tara L Spires-Jones; Leora M Fox; Anete Rozkalne; Rose Pitstick; George A Carlson; Aleksey G Kazantsev
Journal:  Front Pharmacol       Date:  2012-03-12       Impact factor: 5.810

5.  Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells.

Authors:  Claudia Compagnucci; Sara Di Siena; Maria Blaire Bustamante; Daniele Di Giacomo; Monia Di Tommaso; Mauro Maccarrone; Paola Grimaldi; Claudio Sette
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

6.  A systems approach to prion disease.

Authors:  Daehee Hwang; Inyoul Y Lee; Hyuntae Yoo; Nils Gehlenborg; Ji-Hoon Cho; Brianne Petritis; David Baxter; Rose Pitstick; Rebecca Young; Doug Spicer; Nathan D Price; John G Hohmann; Stephen J Dearmond; George A Carlson; Leroy E Hood
Journal:  Mol Syst Biol       Date:  2009-03-24       Impact factor: 11.429

Review 7.  The Neurodevelopmental Hypothesis of Huntington's Disease.

Authors:  Ellen van der Plas; Jordan L Schultz; Peg C Nopoulos
Journal:  J Huntingtons Dis       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.